Our Program

The Blood Diseases Center at USC Norris Comprehensive Cancer Center brings leading-edge technology to the treatment and study of diseases of the blood – both malignant and non-malignant blood disorders – bone marrow and the lymphatic and other related systems. We treat some of the most complex cases in the Los Angeles area, giving you the benefit of our deep experience.

Our physicians stay up-to-date with research that allows them to make difficult diagnoses. Many of our physicians have been recognized as some of the Best Doctors in America. We provide specialized treatment for conditions including anemia, bleeding and clotting disorders, acute and chronic leukemia, multiple myeloma, myelodysplastic and myeloproliferative disorders, lymphomas, immune deficiencies and AIDS-associated malignancies.

The USC Blood and Marrow Transplant Program is approved by the Foundation for the Accreditation of Cellular Therapy (FACT) for both autologous (self) and allogeneic (donor) transplants. Our patients have access to one of the world’s largest registries of blood donors for potential matches through our participation in the National Marrow Donor Program. For patients without a full match, we offer transplant from haploidetentical, or partial-match, donors. In addition, we are a pioneer in research on micro-transplantation, a novel treatment approach for patients with blood cancers that overcomes some of the major limitations of standard allogeneic stem cell transplantation, including Graft vs. Host Disease, a limited supply of matched donors, the need for long-term immunosuppression and toxicity from preparative regimen. Micro-transplantation also allows our patients to receive less chemotherapy and fewer immunosuppressive drugs, thus improving quality of life for patients.

In addition to our pioneering research in microtransplantation, we are conducting basic, translational and clinical research in a number of blood disorders. With an extensive portfolio of clinical trials, qualified patients can receive alternative therapies that may improve their outcomes.

Our Approach

We take a carefully balanced approach to patient care, integrating clinical research and innovative programs that emphasize maintaining your quality of life, despite having received a cancer diagnosis. We understand that each person is unique, which is why we’re dedicated to involving you in a care plan that fits your unique needs and lifestyle.

We seamlessly weave together a multidisciplinary team that treats you from diagnosis to imaging and, finally, to treatment and after-care and support. Your team meets weekly with a board of specialists who confer on your specific condition and circumstances. When you have the advantage of care from a coordinated team, you’ll receive the latest treatments, expert physicians and attention to detail that improves outcomes and reduces complications.

Our Physicians

Mojtaba Akhtari, MD

Featured areas of focus:
Leukemias
Myelodysplastic Syndromes
Myeloproliferative Disorders
Familial Leukemias
Immune Cytopenias
Bone Marrow Transplant

Preet M. Chaudhary, MD, PhD

Featured areas of focus:
Acute Leukemias
Lymphomas
Allogeneic Bone Marrow Transplant

Kevin Kelly, MD, PhD

Featured areas of focus:
Leukemia
Myeloma
Lymphoma

Howard Liebman, MD

Featured areas of focus:
Thrombotic and Bleeding Disorders
Immune Blood Disorders
Bone Marrow Failure
Syndromes

Akil Merchant, MD

Featured areas of focus:
Acute Leukemias
Allogeneic Bone Marrow Transplant

Ann Mohrbacher, MD

Featured areas of focus:
Multiple Myeloma
Lymphoma
Bone Marrow Transplant
Leukemia

Casey O’Connell, MD

Featured areas of focus:
Immune Blood Disorders
Bone Marrow Failure
Syndromes
Anemia
Lymphoma
Leukemia
Clotting Disorders
Myeloproliferative Disorders

Giridharan Ramsingh, MD

Featured areas of focus:
Acute Leukemia
Allogeneic Bone Marrow Transplant

Anil Tulpule, MD

Featured areas of focus:
Lymphomas
Hodgkin’s Disease
HIV-related Lymphomas
HIV-related Kaposi’s Sarcoma

Ilene Weitz, MD

Featured areas of focus:
Blood Clotting Disorders
Immune Blood Diseases
Hematologic Malignancies